Choosing the Right Treatment Option for the Right R/M HNSCC Patient: Should We Adhere to PFE for First-Line Therapy?

by Katharina Lübbers, Mykola Pavlychenko, Theresa Wald, Susanne Wiegand, Andreas Dietz, Veit Zebralla, Gunnar Wichmann
Published 2021-07-01

Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC)

by Julia Siemert, Theresa Wald, Marlen Kolb, Isolde Pettinella, Ulrike Böhm, Markus Pirlich, Susanne Wiegand, Andreas Dietz, Gunnar Wichmann
Published 2021-07-01

Standardized Diagnostics Including PET-CT Imaging, Bilateral Tonsillectomy and Neck Dissection Followed by Risk-Adapted Post-Operative Treatment Favoring Radio-Chemotherapy Improve...

by Gunnar Wichmann, Maria Willner, Thomas Kuhnt, Regine Kluge, Tanja Gradistanac, Theresa Wald, Sandra Fest, Florian Lordick, Andreas Dietz, Susanne Wiegand, Veit Zebralla
Published 2021-05-01

Obtaining Patient-Reported Outcomes Electronically With “OncoFunction” in Head and Neck Cancer Patients During Aftercare

by Veit Zebralla, Juliane Müller, Theresa Wald, Andreas Boehm, Gunnar Wichmann, Thomas Berger, Klemens Birnbaum, Katharina Heuermann, Steffen Oeltze-Jafra, Thomas Neumuth, Susanne Singer, Matthias Büttner, Andreas Dietz, Susanne Wiegand
Published 2020-11-01

Discrimination of Head and Neck Squamous Cell Carcinoma Patients and Healthy Adults by 10-Color Flow Cytometry: Development of a Score Based on Leukocyte Subsets

by Gunnar Wichmann, Clara Gaede, Susanne Melzer, Jozsef Bocsi, Sylvia Henger, Christoph Engel, Kerstin Wirkner, John Ross Wenning, Theresa Wald, Josefine Freitag, Maria Willner, Marlen Kolb, Susanne Wiegand, Markus Löffler, Andreas Dietz, Attila Tárnok
Published 2019-06-01